The proxy reveals extreme dilution risk: the Series F PIPE alone could increase shares outstanding ~30-fold. Combined with an existing equity line of credit and the pending Realbotix acquisition, the stock faces massive overhang. The reverse split request (third in 2026) signals Nasdaq compliance is fragile. Monitor the November 10 vote outcome — if the Series F issuance is approved, expect continued selling pressure from conversion-related dilution.
Price Chart
Executive Summary
Onconetix (ONCO) filed its definitive proxy statement for the November 10, 2026 annual meeting, seeking shareholder approval for five proposals: re-election of director Josh Epstein, issuance of up to 154.9 million shares upon conversion of Series F Preferred Stock (a $30.2M PIPE completed July 29, 2026), a reverse stock split (1:2 to 1:15), ratification of auditor MaloneBailey, and an adjournment proposal. The filing is dominated by massive potential dilution (the Series F conversion alone could increase the share count by ~30x from the current 5.2M shares outstanding) and the company's need for additional reverse split authority to maintain Nasdaq listing, signaling severe financial distress.
Key Facts
- Seeking approval to issue up to 154,856,150 shares upon conversion of Series F Preferred Stock issued in a $30.2M PIPE on July 29, 2026.
- Current shares outstanding: 5,241,486 as of record date September 29, 2026.
- Seeking authority for a reverse stock split at ratios from 1:2 to 1:15 to maintain Nasdaq compliance.
- Company has already executed two reverse splits in 2026 (1:5 in March, 1:10 in May) and has existing authority for additional splits up to 1:10.
- CEO David A. White paid monthly base salary of $21,700; no named executive officers held any equity awards as of December 31, 2025.
- Audit fees for FY2025 were $417,974, up from $267,800 in FY2024.
- Series F Preferred Stock carries a floor conversion price of $0.19534 per share and a 15% default dividend rate upon triggering events.
Financial Impact
Potential dilution of up to 154.9M shares (approximately 30x current outstanding shares) from Series F conversion; $30.2M PIPE proceeds already received.
Risk Factors
- Massive dilution from Series F Preferred Stock conversion (up to 154.9M shares vs 5.2M currently outstanding).
- Nasdaq delisting risk if reverse split authority is not granted or if bid price falls below $1.00 again.
- Additional dilution from existing equity line of credit and pending Realbotix acquisition.
- Variable conversion price on Series F Preferred Stock creates downward price pressure as conversion becomes more attractive at lower stock prices.
- No named executive officers hold equity, indicating lack of insider alignment with shareholders.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEF 14A Filing (Primary) | 0001213900-26-107480 |
| Document: 0001213900-26-107480-index-headers.html | 0001213900-26-107480 |
| Document: 0001213900-26-107480-index.html | 0001213900-26-107480 |
| Document: 0001213900-26-107480.txt | 0001213900-26-107480 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | $0.3500 | awaiting T+20 | — | $0.3990 (+14.00%) |
Oct 23, 2026 3d ago | DEFA14A | $0.4180 | awaiting T+20 | — | $0.3990 (−4.55%) |
Oct 23, 2026 3d ago | 8-K | $0.4180 | awaiting T+20 | — | $0.3990 (−4.55%) |
Oct 23, 2026 3d ago | 425 | $0.4180 | awaiting T+20 | — | $0.3990 (+4.55%) |
Oct 7, 2026 19d ago | DEF 14A | $0.5970 | awaiting T+20 | — | $0.3990 (+33.17%) |
Sep 14, 2026 6w ago | DEFA14A / 8-K | $0.6374 $0.5904 | ▼ −7.37% | ▼ −9.64% | $0.3990 (−37.40%) |
Sep 14, 2026 6w ago | 8-K | $0.6374 $0.5904 | ▲ +7.37% | ▲ +9.64% | $0.3990 (+37.40%) |
Sep 14, 2026 6w ago | 425 | $0.6374 $0.5904 | ▲ +7.37% | ▲ +9.64% | $0.3990 (+37.40%) |
Sep 4, 2026 7w ago | EFFECT | $1.02 $0.6730 | ▲ +34.02% | ▲ +34.62% | $0.3990 (+60.88%) |
Sep 3, 2026 7w ago | 425 | $0.7390 $0.7337 | ▼ −0.72% | ▲ +0.47% | $0.3990 (−46.01%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers